XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - ValueSet

29,056 resources

By Version

R2: 0
R2B: 0
R3: 1,154
R4: 23,662
R4B: 244
R5: 3,968
R6: 28

By Authority

none: 8,611
hl7: 17,881
ihe: 218
national: 1,286
who: 1,060

By Realm

none: 5,874
au: 87
be: 108
br: 73
ca: 244
ch: 395
cl: 150
cr: 11
cz: 48
de: 680
dk: 475
ee: 66
eu: 349
fi: 4
fr: 810
il: 144
in: 48
it: 92
jp: 71
nl: 958
no: 6
nz: 17
pl: 23
se: 10
tw: 161
uk: 23
us: 13,139
uv: 4,925
vn: 23
other: 5

Start Prev Rows 6400 - 6600 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Auth
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1258	Substance Use Disorder Long Acting Medication	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1259	Substance Use Disorder Short Acting Medication	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1260	Viloxazine	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1266	Diabetic Retinopathy Severity Level	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1272	Diabetes	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1273	Diabetes	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.195.11.1003	Counseling for Nutrition	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.195.11.1004	Counseling for Nutrition	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.195.12.1003	Counseling for Nutrition	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1001	Antibiotic Medications for Pharyngitis	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1078	Nifedipine Medications	active	2022-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1080	Contraceptive Medications	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1109	Meperidine Medications	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1129	Desiccated Thyroid Medications	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1143	Isotretinoin	active	2022-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1167	Dipyridamole Medications	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1205	Leucovorin	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1211	Aspirin and Other Antiplatelets	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1212	DTaP Vaccine	active	2024-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1214	Hepatitis A Vaccine	active	2018-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1216	Hepatitis B Vaccine	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1220	Child Influenza Vaccine	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1222	Inactivated Polio Vaccine (IPV)	active	2021-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1228	Pneumococcal Conjugate Vaccine	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1232	Rotavirus Vaccine (3 dose schedule)	active	2018-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1234	Varicella Zoster Vaccine (VZV)	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1235	Measles, Mumps and Rubella (MMR) Vaccine	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1252	Guanfacine Medications	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1255	Megestrol Medications	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1256	Meprobamate Medications	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1266	Aromatase Inhibitors	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1267	Glucocorticoids (oral only)	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1481	Potentially Harmful Nonbenzodiazepine Hypnotics for Older Adults	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1482	Potentially Harmful Antiinfectives for Older Adults	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1517	Dementia Medications	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1530	Antidepressant Medication	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.11.1532	Potentially Harmful Antipsychotics for Older Adults	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1001	Antibiotic Medications for Pharyngitis	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1080	Contraceptive Medications	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1143	Isotretinoin	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1170	Varicella Zoster Vaccine (VZV)	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1205	Leucovorin	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1211	Aspirin and Other Antiplatelets	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1213	Antidepressant Medication	active	2021-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1214	DTaP Vaccine	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1215	Hepatitis A Vaccine	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1216	Hepatitis B Vaccine	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1218	Child Influenza Vaccine	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1219	Inactivated Polio Vaccine (IPV)	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1221	Pneumococcal Conjugate Vaccine	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1223	Rotavirus Vaccine (3 dose schedule)	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1224	Measles, Mumps and Rubella (MMR) Vaccine	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1265	Aromatase Inhibitors	active	2018-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1266	Glucocorticoids (oral only)	active	2018-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1480	Potentially Harmful Nonbenzodiazepine Hypnotics for Older Adults	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1481	Potentially Harmful Antiinfectives for Older Adults	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1510	Dementia Medications	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1522	Potentially Harmful Benzodiazepines for Older Adults	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1523	Potentially Harmful Antipsychotics for Older Adults	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1005	Bilateral Mastectomy	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1009	Primary THA Procedure	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1015	Flexible Sigmoidoscopy	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1016	Flexible Sigmoidoscopy	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1017	Flexible Sigmoidoscopy	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1020	Fecal Occult Blood Test (FOBT)	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1023	Group A Streptococcus Test	active	2024-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1024	HbA1c Laboratory Test	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1026	Hysterectomy with No Residual Cervix	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1027	Hysterectomy with No Residual Cervix	active	2024-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1035	Total Colectomy	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1036	Total Colectomy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1055	XRay Study	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1061	Gastric Bypass Surgery	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1062	Gastric Bypass Surgery	active	2018-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1080	Primary THA Procedure	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1084	History of bilateral mastectomy	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1085	History of bilateral mastectomy	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1086	Status Post Left Mastectomy	active	2018-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1087	Status Post Right Mastectomy	active	2018-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1089	Unilateral Mastectomy, Unspecified Laterality	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1090	Unilateral Mastectomy, Unspecified Laterality	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1091	Status Post Left Mastectomy	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1092	Status Post Right Mastectomy	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1096	Major Transplant	active	2021-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1097	Major Transplant	active	2021-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1132	Unilateral Mastectomy Left	active	2021-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1133	Unilateral Mastectomy Right	active	2021-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1134	Hysterectomy with No Residual Cervix	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1135	Hysterectomy with No Residual Cervix	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1140	Bilateral Mastectomy	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1143	Total Colectomy	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1144	Unilateral Mastectomy Left	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1145	Unilateral Mastectomy Right	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1148	Palliative Intervention	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1005	Bilateral Mastectomy	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1006	Primary THA Procedure	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1010	Flexible Sigmoidoscopy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1011	Fecal Occult Blood Test (FOBT)	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1012	Group A Streptococcus Test	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1013	HbA1c Laboratory Test	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1014	Hysterectomy with No Residual Cervix	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1019	Total Colectomy	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1034	XRay Study	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1050	Gastric Bypass Surgery	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1068	History of bilateral mastectomy	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1069	Status Post Left Mastectomy	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1070	Status Post Right Mastectomy	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1071	Unilateral Mastectomy, Unspecified Laterality	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1075	Major Transplant	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1133	Unilateral Mastectomy Left	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1134	Unilateral Mastectomy Right	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1135	Palliative Care Intervention	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.11.1064	Anaphylactic Reaction to DTaP Vaccine	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.11.1100	Malabsorption Syndromes	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.11.1102	Malabsorption Syndromes	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.11.1105	Intussusception	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.11.1106	Intussusception	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.11.1107	Influenza Virus LAIV Vaccine	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.11.1108	Influenza Virus LAIV Vaccine Administered	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.12.1031	Anaphylactic Reaction to DTaP Vaccine	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.12.1050	Malabsorption Syndromes	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.12.1056	Intussusception	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1004.2446	Lower Extremity Visual Inspection Test	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1004.2447	Pedal Pulse Result or Finding	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1004.2448	Monofilament Test Result or Finding	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1004.2449	Monofilament Tests	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1004.2450	Lower Extremity Neurological Assessment Result or Finding	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1004.2451	Lower Extremity Neurological Tests	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1004.2452	Lower Extremity Visual Inspection Result or Finding	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1004.2616	Autonomous Eye Exam Result or Finding	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.1577	Pharmacologic Therapy for Hypertension	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1036	Chronic Kidney Disease, Stage 5	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1037	Chronic Kidney Disease, Stage 5	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1049	Patient Provider Interaction	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1058	Psych Visit for Family Psychotherapy	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1063	Occupational Therapy Evaluation	active	2017-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1067	Dementia and Mental Degenerations	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1068	Dementia and Mental Degenerations	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1069	Standardized Tools for Assessment of Cognition	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1071	Radiation Treatment Management	active	2017-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1072	Radiation Treatment Management	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1073	Standardized Pain Assessment Tool	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1078	Cancer	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1079	Cancer	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1080	Chemotherapy Administration	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1081	Chemotherapy Administration	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.111	Ophthalmological Services	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.113	Prostate Cancer Treatment	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.118	Initial Myocardial Infarction	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.119	Initial Myocardial Infarction	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.120	Coronary Artery Disease No MI	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1238	Ejection Fraction	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1243	Psychoanalysis	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1244	Renal Failure Due to ACE Inhibitor	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1251	Group Psychotherapy	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1256	Allergy to ACE Inhibitor or ARB	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1257	Intolerance to ACE Inhibitor or ARB	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.133	Beta Blocker Therapy	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1333	Allergy to Beta Blocker Therapy	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1334	Intolerance to Beta Blocker Therapy	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1341	Heart Rate	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1342	Beta Blocker Therapy for LVSD	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1344	Acute and Subacute Iridocyclitis	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1353	Limited Life Expectancy	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1363	Annual Wellness Visit	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1364	Macular Exam	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1372	Tobacco Use Screening	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1374	Bone Scan	active	2018-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1377	Level of Severity of Retinopathy Findings	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1381	Macular Edema Findings Present	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1401	Cognitive Assessment	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1402	Cup to Disc Ratio	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1403	Optic Disc Exam for Structural Abnormalities	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1509	Acute and Subacute Iridocyclitis	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1521	Burn Confined to Eye and Adnexa	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1523	Burn Confined to Eye and Adnexa	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1524	Cataract Secondary to Ocular Disorders	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1526	Cataract Secondary to Ocular Disorders	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1527	Cataract Surgery	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1528	Cataract Surgery	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1529	Cataract Congenital	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1530	Cataract Congenital	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1532	Cataract Mature or Hypermature	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1534	Cataract Mature or Hypermature	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1535	Cataract Posterior Polar	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1537	Cataract Posterior Polar	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1538	Certain Types of Iridocyclitis	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1540	Certain Types of Iridocyclitis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1542	Chronic Iridocyclitis	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1543	Chronic Iridocyclitis	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1544	Cloudy Cornea	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1546	Cloudy Cornea	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1548	Corneal Edema	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1549	Corneal Edema	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1550	Disorders of Cornea Including Corneal Opacity	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1552	Disorders of Cornea Including Corneal Opacity	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1561	Glaucoma	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1562	Glaucoma	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1564	Hereditary Corneal Dystrophies	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1566	Hereditary Corneal Dystrophies	active	2021-02	us	hl7